Philippe Genereux, MD
Cardiovascular Disease · New York, NYNPI 1114179264
Payments from drug & device makers
Across 1,517 payments — averaging $2922.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$3.2M
- Opsens Inc.$319K
- Saranas, Inc.$318K
- Cardiva Medical, Inc.$252K
- Abbott$138K
- Medtronic$73K
- plus $123K from 29 others
Across 3 payments — averaging $499.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 771 | $3,209,326 |
| Opsens Inc. | 78 | $318,994 |
| Saranas, Inc. | 57 | $318,466 |
| Cardiva Medical, Inc. | 49 | $251,651 |
| Abbott | 207 | $138,459 |
| Medtronic(2 entities) | 195 | $72,531 |
| Boston Scientific | 38 | $51,072 |
| Cardiovascular Systems Inc. | 16 | $30,687 |
| Shockwave Medical, Inc | 5 | $19,642 |
| Abiomed | 19 | $13,298 |
| Siemens Medical Solutions USA, Inc. | 5 | $2,552 |
| Teleflex LLC | 2 | $1,424 |
| Cordis US CORP. | 2 | $960 |
| Pi-cardia, Inc. | 2 | $629 |
| W. L. Gore & Associates, Inc. | 21 | $516 |
| Haemonetics Corporation | 4 | $334 |
| Jenavalve Technology, Inc. | 2 | $249 |
| Penumbra, Inc. | 1 | $235 |
| GE HealthCare | 3 | $212 |
| Biolife, L.L.C. | 1 | $200 |
| Heartflow, Inc. | 3 | $198 |
| Pfizer | 12 | $187 |
| Acist Medical Systems, Inc. | 1 | $132 |
| Cardinal Health 200 LLC | 2 | $122 |
| Stryker | 1 | $110 |
| Merit Medical Systems Inc | 1 | $109 |
| Inari Medical, Inc. | 1 | $89 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $88 |
| E.r. Squibb & Sons, L.L.C. | 5 | $87 |
| Irhythm Technologies, Inc. | 2 | $56 |
| Arrow International, Inc. | 1 | $37 |
| Chiesi USA, Inc. | 2 | $30 |
| Philips North America LLC | 1 | $20 |
| Amgen | 1 | $17 |
| AstraZeneca | 1 | $13 |
How this compares
$4,432,730 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in New York
- James MinNew York$41.1M
- Robert RosensonNew York$6.9M
- Roxana MehranNew York$6.4M
- Roger HajjarNew York$5.2M
- Gregg StoneNew York$3.7M
- Valentin FusterNew York$2.9M
- Tamim NazifNew York$2.2M
- Howard WeintraubNew York$1.7M
- Anuradha Lala-TrindadeNew York$1.5M
- Cezar StaniloaeNew York$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.